Asia-Pacific Oncology Ablation Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Oncology Ablation Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Radiofrequency Ablation Market Performance (Volume)
  • 2.1.2 Microwave Ablation Market Performance (Volume)
  • 2.1.3 Cryoablation Market Performance (Volume)
  • 2.1.4 Ethanol Ablation Market Performance (Volume)
  • 2.1.5 Irreversible Electroporesis (IRE) Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Radiofrequency Ablation Market Performance (Value)
  • 2.1.2 Microwave Ablation Market Performance (Value)
  • 2.1.3 Cryoablation Market Performance (Value)
  • 2.1.4 Ethanol Ablation Market Performance (Value)
  • 2.1.5 Irreversible Electroporesis (IRE) Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospitals Market Performance (Volume)
  • 3.1.2 Clinical laboratories Market Performance (Volume)
  • 3.1.3 Academic and Research Institutes Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Accuray Inc.
  • 4.1.1 Accuray Inc. Profiles
  • 4.1.2 Accuray Inc. Product Information
  • 4.1.3 Accuray Inc. Oncology Ablation Business Performance
  • 4.1.4 Accuray Inc. Oncology Ablation Business Development and Market Status
• 4.2 AngioDynamics
  • 4.2.1 AngioDynamics Profiles
  • 4.2.2 AngioDynamics Product Information
  • 4.2.3 AngioDynamics Oncology Ablation Business Performance
  • 4.2.4 AngioDynamics Oncology Ablation Business Development and Market Status
• 4.3 APRO KOREA
  • 4.3.1 APRO KOREA Profiles
  • 4.3.2 APRO KOREA Product Information
  • 4.3.3 APRO KOREA Oncology Ablation Business Performance
  • 4.3.4 APRO KOREA Oncology Ablation Business Development and Market Status
• 4.4 Boston Scientific
  • 4.4.1 Boston Scientific Profiles
  • 4.4.2 Boston Scientific Product Information
  • 4.4.3 Boston Scientific Oncology Ablation Business Performance
  • 4.4.4 Boston Scientific Oncology Ablation Business Development and Market Status
• 4.5 BSD Medical
  • 4.5.1 BSD Medical Profiles
  • 4.5.2 BSD Medical Product Information
  • 4.5.3 BSD Medical Oncology Ablation Business Performance
  • 4.5.4 BSD Medical Oncology Ablation Business Development and Market Status
• 4.6 Celon AG (Olympus)
  • 4.6.1 Celon AG (Olympus) Profiles
  • 4.6.2 Celon AG (Olympus) Product Information
  • 4.6.3 Celon AG (Olympus) Oncology Ablation Business Performance
  • 4.6.4 Celon AG (Olympus) Oncology Ablation Business Development and Market Status
• 4.7 Covidien
  • 4.7.1 Covidien Profiles
  • 4.7.2 Covidien Product Information
  • 4.7.3 Covidien Oncology Ablation Business Performance
  • 4.7.4 Covidien Oncology Ablation Business Development and Market Status
• 4.8 Elekta AB
  • 4.8.1 Elekta AB Profiles
  • 4.8.2 Elekta AB Product Information
  • 4.8.3 Elekta AB Oncology Ablation Business Performance
  • 4.8.4 Elekta AB Oncology Ablation Business Development and Market Status
• 4.9 Galil Medical
  • 4.9.1 Galil Medical Profiles
  • 4.9.2 Galil Medical Product Information
  • 4.9.3 Galil Medical Oncology Ablation Business Performance
  • 4.9.4 Galil Medical Oncology Ablation Business Development and Market Status
• 4.10 HealthTronics Inc.
  • 4.10.1 HealthTronics Inc. Profiles
  • 4.10.2 HealthTronics Inc. Product Information
  • 4.10.3 HealthTronics Inc. Oncology Ablation Business Performance
  • 4.10.4 HealthTronics Inc. Oncology Ablation Business Development and Market Status
• 4.11 MedWaves Incorporated
• 4.12 Misonix
• 4.13 APRO KOREA
• 4.14 Boston Scientific
• 4.15 BSD Medical

5 Market Performance for Manufacturers

• 5.1 Asia-Pacific Oncology Ablation Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Asia-Pacific Oncology Ablation Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Asia-Pacific Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Asia-Pacific Oncology Ablation Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Japan Market Performance for Manufacturers
  • 6.2.1 Japan Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Japan Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Japan Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Japan Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Korea Market Performance for Manufacturers
  • 6.3.1 South Korea Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Korea Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Korea Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Korea Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Taiwan Market Performance for Manufacturers
  • 6.4.1 Taiwan Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Taiwan Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Taiwan Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Taiwan Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 India Market Performance for Manufacturers
  • 6.5.1 India Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 India Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 India Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 India Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Southeast Asia Market Performance for Manufacturers
  • 6.6.1 Southeast Asia Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Southeast Asia Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Southeast Asia Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Southeast Asia Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Australia Market Performance for Manufacturers
  • 6.7.1 Australia Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Australia Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Australia Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Australia Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Oncology Ablation Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Oncology Ablation Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Oncology Ablation Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Oncology Ablation Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Asia-Pacific Oncology Ablation Market Performance (Sales Point)

• 7.1 Asia-Pacific Oncology Ablation Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Asia-Pacific Oncology Ablation Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Asia-Pacific Oncology Ablation Price (USD/Unit) by Regions 2013-2018
• 7.4 Asia-Pacific Oncology Ablation Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Asia-Pacific Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Japan Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Korea Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Taiwan Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 India Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Southeast Asia Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Oncology Ablation Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospitals Industry
• 11.2 Clinical laboratories Industry
• 11.3 Academic and Research Institutes Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Asia-Pacific Oncology Ablation Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Asia-Pacific Oncology Ablation Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Japan Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Korea Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Taiwan Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 India Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Southeast Asia Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Australia Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Oncology Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Radiofrequency Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Microwave Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.4 Cryoablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.5 Ethanol Ablation Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospitals Sales and and Growth Rate 2019-2024
  • 12.4.3 Clinical laboratories Sales and and Growth Rate 2019-2024
  • 12.4.4 Academic and Research Institutes Sales and and Growth Rate 2019-2024
  • 12.4.5 Others Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Asia-Pacific Oncology Ablation Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Asia-Pacific Oncology Ablation Gross Profit Trend 2019-2024

13 Conclusion